|
US3898330A
(en)
|
1973-08-01 |
1975-08-05 |
Squibb & Sons Inc |
Corticosteroid phosphate salts/neomycin sulfate ophthalmic
|
|
JPS58134404U
(ja)
|
1982-03-04 |
1983-09-09 |
大成道路株式会社 |
コンクリ−ト舗装装置
|
|
US4525359A
(en)
|
1982-12-10 |
1985-06-25 |
Greenway Frank L Iii |
Treatment for selective weight control
|
|
JPS59146905A
(ja)
|
1983-02-07 |
1984-08-23 |
Nippon Mining Co Ltd |
水素製造装置におけるスチ−ム供給量の制御方法
|
|
JPS59155313U
(ja)
|
1983-04-02 |
1984-10-18 |
山内 真治 |
家具の組立装置
|
|
NZ212204A
(en)
*
|
1984-06-04 |
1988-07-28 |
Merck & Co Inc |
Growth-promoting compositions containing hydroxylic compounds
|
|
GB8426672D0
(en)
|
1984-10-22 |
1984-11-28 |
Erba Farmitalia |
Pharmaceutical compositions
|
|
JPH0696521B2
(ja)
|
1986-01-31 |
1994-11-30 |
千寿製薬株式会社 |
眼局所投与用眼圧降下剤
|
|
FR2602423B1
(fr)
|
1986-08-08 |
1989-05-05 |
Ethypharm Sa |
Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
|
|
US5270305A
(en)
*
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
|
CA2030174C
(en)
*
|
1990-01-10 |
1996-12-24 |
Anthony H. Cincotta |
Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
|
|
US5126147A
(en)
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
|
US5919827A
(en)
*
|
1990-07-11 |
1999-07-06 |
Sepracor Inc. |
Method for treating asthma using optically pure R(-) salmeterol
|
|
SE9302777D0
(sv)
*
|
1993-08-27 |
1993-08-27 |
Astra Ab |
Process for conditioning substances
|
|
US5658549A
(en)
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
CA2123909C
(en)
|
1991-12-18 |
2002-10-01 |
Christer Carl Gustav Carling |
New combination of formoterol and budesonide
|
|
DK0717987T3
(da)
|
1991-12-18 |
2001-11-12 |
Minnesota Mining & Mfg |
Suspension-aerosol-formuleringer
|
|
US5314916A
(en)
|
1993-04-19 |
1994-05-24 |
Alcon Laboratories, Inc. |
B2 adrenegic agonists and use thereof in the treatment of glaucoma
|
|
US6316443B1
(en)
*
|
1994-08-04 |
2001-11-13 |
Merck & Co., Inc. |
Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
|
|
GB9512854D0
(en)
|
1995-06-23 |
1995-08-23 |
Wellcome Found |
Novel formulation
|
|
GB2317359B
(en)
*
|
1996-05-13 |
1999-06-09 |
Seagate Technology |
Shaped-beam laser texturing of magnetic media
|
|
US5855913A
(en)
*
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US6066675A
(en)
|
1996-09-13 |
2000-05-23 |
The Regents Of The University Of California |
Method for treatment of retinal diseases
|
|
JP4335316B2
(ja)
|
1996-09-19 |
2009-09-30 |
ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン |
アルギネートまたは修飾アルギネートのようなポリサッカライドを含むポリマー
|
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
|
US5837283A
(en)
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
|
TW469832U
(en)
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
|
SK122199A3
(en)
|
1997-03-18 |
2000-12-11 |
Basf Ag |
Methods and compositions for modulating responsiveness to corticosteroids
|
|
US6656508B2
(en)
|
1997-04-17 |
2003-12-02 |
Amgen Inc. |
Sustained-release alginate gels
|
|
EP0979081A4
(en)
|
1997-04-30 |
2003-05-02 |
Bridge Pharma Inc |
COMPOSITION AND METHODS USING EUTOMER
|
|
US6310669B1
(en)
*
|
1997-05-26 |
2001-10-30 |
Mitsubishi Denki Kabushiki Kaisha |
TFT substrate having connecting line connect to bus lines through different contact holes
|
|
US20010044584A1
(en)
*
|
1997-08-28 |
2001-11-22 |
Kensey Kenneth R. |
In vivo delivery methods and compositions
|
|
SE9703407D0
(sv)
|
1997-09-19 |
1997-09-19 |
Astra Ab |
New use
|
|
JPH11106334A
(ja)
|
1997-09-30 |
1999-04-20 |
Saitama Daiichi Seiyaku Kk |
尿失禁治療剤
|
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
|
ATE231186T1
(de)
*
|
1998-07-21 |
2003-02-15 |
Danisco |
Lebensmittel
|
|
US20040152664A1
(en)
|
1998-09-02 |
2004-08-05 |
Allergan, Inc. |
Prednisolone compositions
|
|
US6384259B1
(en)
*
|
1998-11-16 |
2002-05-07 |
Medimmune Oncology, Inc. |
Stable amorphous amifostine compositions and dosage form
|
|
WO2001019373A2
(en)
|
1999-09-17 |
2001-03-22 |
Basf Aktiengesellschaft |
Methods and compositions for modulating responsiveness to corticosteroids
|
|
GB9924992D0
(en)
*
|
1999-10-21 |
1999-12-22 |
Glaxo Group Ltd |
Pharmaceutical aerosol formulations
|
|
US6569903B2
(en)
|
1999-12-07 |
2003-05-27 |
Rohto Pharmaceutical Co., Ltd. |
Ophthalmic compositions
|
|
US20040208910A1
(en)
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
GB0012260D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel composition
|
|
AUPQ797700A0
(en)
*
|
2000-06-06 |
2000-06-29 |
Austin Research Institute, The |
Vaccine
|
|
FI20002215A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit
|
|
FI20002216A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit astman hoitoon
|
|
US6936426B2
(en)
*
|
2000-10-06 |
2005-08-30 |
Harbor-Ucla Research And Education Institute |
Detection of antibody mediated inflammatory auto-immune disorders
|
|
AU2002210395A1
(en)
|
2000-11-03 |
2002-05-15 |
Histotech Aps |
A device and a method for sectioning of tissue blocks
|
|
JP4623931B2
(ja)
*
|
2000-12-07 |
2011-02-02 |
エンセラデュス、ファーマシューティカルズ、ベスローテン、フェンノートシャップ |
炎症性疾患の治療用組成物
|
|
US20030022856A1
(en)
|
2001-01-30 |
2003-01-30 |
The Regents Of The University Of Michigan |
Method for sustained release local delivery of drugs for ablation of unwanted tissue
|
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
|
US20030055026A1
(en)
*
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
AR033290A1
(es)
*
|
2001-04-30 |
2003-12-10 |
Glaxo Group Ltd |
Derivados antiinflamatorios de androstano
|
|
US6726714B2
(en)
*
|
2001-08-09 |
2004-04-27 |
Scimed Life Systems, Inc. |
Stent delivery system
|
|
GB0124523D0
(en)
|
2001-10-12 |
2001-12-05 |
Glaxo Group Ltd |
Pharmaceutical combination
|
|
JP2005508220A
(ja)
|
2001-10-24 |
2005-03-31 |
パーリ・ゲーエムベーハー |
薬用組成物調製用具
|
|
US6625078B2
(en)
|
2002-02-11 |
2003-09-23 |
United Memories, Inc. |
Look-ahead refresh for an integrated circuit memory
|
|
EP1476201B1
(en)
|
2002-02-19 |
2008-12-24 |
Resolution Chemicals Limited |
Solvent-based sterilisation of steroids
|
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
|
US6688311B2
(en)
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
|
US7140371B2
(en)
|
2002-03-14 |
2006-11-28 |
Allergan, Inc. |
Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins
|
|
US6643212B1
(en)
|
2002-04-18 |
2003-11-04 |
United Memories, Inc. |
Simultaneous function dynamic random access memory device technique
|
|
US20040028545A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Ta-Chin Wang |
Cylinder assembly for a mini air compressor
|
|
AU2003263717A1
(en)
*
|
2002-09-25 |
2004-04-19 |
Astrazeneca Ab |
A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
|
|
CN1694689A
(zh)
|
2002-09-30 |
2005-11-09 |
阿库斯菲尔公司 |
供吸入的缓释多孔微粒
|
|
US20040208833A1
(en)
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
US20040209850A1
(en)
*
|
2003-04-15 |
2004-10-21 |
Theraquest Biosciences, Llc |
Methods of treating pain and compositions for use therefor
|
|
US9808471B2
(en)
*
|
2003-04-16 |
2017-11-07 |
Mylan Specialty Lp |
Nasal pharmaceutical formulations and methods of using the same
|
|
WO2004103057A2
(en)
*
|
2003-05-15 |
2004-12-02 |
The University Of Georgia Research Foundation, Inc. |
Compositions and methods for inducing adipose tissue cell death
|
|
AU2004241746A1
(en)
|
2003-05-22 |
2004-12-02 |
Nycomed Gmbh |
Salmeterol and ciclesonide combination
|
|
SE0302029D0
(sv)
*
|
2003-07-07 |
2003-07-07 |
Astrazeneca Ab |
Novel process
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
GB2403655A
(en)
|
2003-07-11 |
2005-01-12 |
Cipla Ltd |
Combined pharmaceutical product comprising a beta-2 adrenoreceptor agonist & an antihistamine for treatment of respiratory diseases such as asthma
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2005009375A2
(en)
|
2003-07-22 |
2005-02-03 |
Baxter International Inc. |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
|
WO2005032523A1
(en)
*
|
2003-09-30 |
2005-04-14 |
Acusphere, Inc. |
Injectable, oral, or topical sustained release pharmaceutical formulations
|
|
US20050075900A1
(en)
|
2003-10-02 |
2005-04-07 |
Arguimbau Vincent C. |
Method and apparatus for bulk food marking and tracking with supplier rating system
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
US20050089555A1
(en)
|
2003-10-24 |
2005-04-28 |
Aventis Pharma Deutschland Gmbh |
Medicinal targeted local lipolysis
|
|
AU2004287875B2
(en)
*
|
2003-11-05 |
2011-06-02 |
Bausch + Lomb Ireland Limited |
Modulators of cellular adhesion
|
|
JP4674162B2
(ja)
*
|
2003-11-14 |
2011-04-20 |
千寿製薬株式会社 |
アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
|
|
WO2005051092A2
(en)
*
|
2003-11-20 |
2005-06-09 |
Alteragon Pty Ltd |
Method of decreasing fat deposits and body weight in mammals and birds
|
|
KR100573828B1
(ko)
|
2003-12-29 |
2006-04-26 |
주식회사 하이닉스반도체 |
셀데이터의 손실을 방지하기 위한 반도체 메모리 소자
|
|
US20080270175A1
(en)
|
2003-12-31 |
2008-10-30 |
Klinger Advanced Aesthetics, Inc. |
Systems and methods using a dynamic expert system to provide patients with aesthetic improvement procedures
|
|
CN1640390A
(zh)
|
2004-01-17 |
2005-07-20 |
北京博尔达生物技术开发有限公司 |
注射用新鱼腥草素钠冻干粉针剂及制备方法
|
|
US20050212152A1
(en)
*
|
2004-03-23 |
2005-09-29 |
Reens Daniel J |
System and method for humidifying homes and commercial sites
|
|
US7754230B2
(en)
*
|
2004-05-19 |
2010-07-13 |
The Regents Of The University Of California |
Methods and related compositions for reduction of fat
|
|
EP1778078A2
(en)
|
2004-07-20 |
2007-05-02 |
Allergan, Inc. |
Thermographic assessment of clostridial toxin applications
|
|
JP2008507532A
(ja)
|
2004-07-21 |
2008-03-13 |
セラヴァンス， インコーポレーテッド |
ジアリールエーテルβ２アドレナリン作用性レセプターアゴニスト
|
|
EP1819318A1
(en)
|
2004-11-24 |
2007-08-22 |
Seo Hong Yoo |
Dried forms of aqueous solubilized bile acid dosage formulation
|
|
CN101119733A
(zh)
|
2005-02-18 |
2008-02-06 |
参天制药株式会社 |
减轻或避免甾族化合物副作用的方法
|
|
US20100215710A1
(en)
*
|
2005-04-08 |
2010-08-26 |
The Regents Of The University Of California |
Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
|
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
CN1706501A
(zh)
|
2005-05-27 |
2005-12-14 |
沈阳药科大学 |
亲脂性药物环糊精包合物的制备方法
|
|
CN106075449A
(zh)
*
|
2005-07-14 |
2016-11-09 |
尼奥塞蒂克斯公司 |
用于局部脂肪组织治疗的持续释放的增强性脂肪分解性制剂
|
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
|
FR2893845B1
(fr)
*
|
2005-11-30 |
2010-10-29 |
Galderma Sa |
Composition sous forme de spray comprenant un corticoide et une phase huileuse
|
|
US20070178166A1
(en)
*
|
2005-12-15 |
2007-08-02 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US20070178051A1
(en)
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
|
RU2008142388A
(ru)
|
2006-04-03 |
2010-05-10 |
Тева Фармасьютикл Индастриес Лтд. (Il) |
Микрочастицы лекарственного вещества
|
|
DE102007026979A1
(de)
|
2006-10-06 |
2008-04-10 |
Friedrich Siller |
Inhalationsvorrichtung
|
|
AU2007313077B2
(en)
|
2006-10-17 |
2011-06-02 |
Neothetics, Inc. |
Methods, compositions, and formulations for the treatment of thyroid eye disease
|
|
US20100063006A1
(en)
|
2006-11-22 |
2010-03-11 |
American Network Of Lipolysis, Llc |
Compositions and methods to reduce fat and retract skin
|
|
MX2009010675A
(es)
*
|
2007-04-04 |
2009-10-23 |
Theratechnologies Inc |
Formulaciones farmaceuticas de moleculas de la hormona liberadora de la hormona delcrecimiento humana.
|
|
KR101546977B1
(ko)
|
2007-04-24 |
2015-08-24 |
아카시아 파마 리미티드 |
근육 손실의 치료에서의 약물 조합 및 그것의 용도
|
|
US20090208492A1
(en)
|
2007-06-14 |
2009-08-20 |
Elan Pharmaceuticals, Inc. |
Lyophilized Immunoglobulin Formulations and Methods of Preparation
|
|
BRPI0814716A2
(pt)
|
2007-06-22 |
2015-02-24 |
Dompe Spa |
Comprimidos efervescentes para uso em inalação
|
|
US20090143343A1
(en)
*
|
2007-11-13 |
2009-06-04 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
WO2009073051A1
(en)
|
2007-12-03 |
2009-06-11 |
Bridge Pharma, Inc. |
Use of rr/sr-ractopamine
|
|
US20120169732A1
(en)
|
2008-01-09 |
2012-07-05 |
Allergan, Inc. |
Method for analysis of facial appearance to assist medical procedure
|
|
US20130060123A1
(en)
|
2008-01-09 |
2013-03-07 |
Allergan, Inc. |
Method for determining breast volume to assist medical procedure
|
|
KR101184869B1
(ko)
|
2008-04-24 |
2012-09-20 |
이매틱스 바이오테크놀로지스 게엠베하 |
백신을 위한 인간 조직 적합성 항원(ｈｌａ) 종류 ｉ 또는 ｉｉ 분자에 결합하는 종양 관련 펩티드의 신규한 제형
|
|
EP2349090B1
(en)
|
2008-10-17 |
2014-03-26 |
Allergan, Inc. |
Prosthetic implant shell
|
|
CA2740888A1
(en)
|
2008-10-17 |
2010-04-22 |
Allergan, Inc. |
Prosthetic implant shell
|
|
US8101593B2
(en)
|
2009-03-03 |
2012-01-24 |
Kythera Biopharmaceuticals, Inc. |
Formulations of deoxycholic acid and salts thereof
|
|
US9132084B2
(en)
*
|
2009-05-27 |
2015-09-15 |
Neothetics, Inc. |
Methods for administration and formulations for the treatment of regional adipose tissue
|
|
GB2487868B
(en)
|
2010-01-15 |
2014-12-10 |
Neothetics Inc |
Lyophilized cake formulations
|
|
BR112013012994A2
(pt)
*
|
2010-11-24 |
2016-09-13 |
Lithera Inc |
formulações monoterapêuticas de beta-agonista de longa duração, lipofílicas e seletivas e métodos para o tratamento cosmético da adiposidade e saliência de contorno
|
|
CA2824317C
(en)
|
2011-01-19 |
2014-12-16 |
Terakine Therapeutics, Inc. |
Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia
|
|
US20120237492A1
(en)
|
2011-02-18 |
2012-09-20 |
Kythera Biopharmaceuticals, Inc. |
Treatment of submental fat
|
|
US8653058B2
(en)
|
2011-04-05 |
2014-02-18 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
|
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
|
US20140094662A1
(en)
|
2012-10-03 |
2014-04-03 |
Allergan, Inc. |
Method of assessing capsular formation and/or contracture
|
|
WO2014055895A1
(en)
|
2012-10-05 |
2014-04-10 |
Allergan, Inc. |
Injectable device and method for sculpting, augmenting or correcting facial features such as the chin
|
|
SG11201600237YA
(en)
|
2012-11-21 |
2016-02-26 |
Topokine Therapeutics Inc |
Methods and compositions for locally increasing body fat
|